← Back to all trials
Completed
NCT07101263
Whey Protein Comparisons for Blood Lipid Effects
Conditions: Cholesterol
Sex: All
Ages: 21 Years – 59 Years
Healthy volunteers: Yes
Phase: NA
Enrollment: 60
Sponsor: Medinutra LLC
Location: Medinutra LLC Dublin Ohio
Summary
The goal of this clinical trial is to learn if hydrolyzed whey protein can help serum cholesterol stay in normal range in adults. As a side inquiry, a few blood measures will be taken that are relevant to low level inflammation. The main questions the study aims to answer are:
* Will hydrolyzed whey lower serum cholesterol readings in adults with starting values in the upper end of normal to the lower end of elevated?
* Will the hydrolyzed whey affect a general measure of inflammation and two measures of indirect relevance to inflammation?
Researchers will compare hydrolyzed whey to a conventional whey (a control protein not expected to affect serum cholesterol readings) to see if the hydrolyzed whey lowers serum cholesterol.
Participants will:
* Drink one protein beverage every day for 6 weeks;
* Go to a LabCorp facility for a blood draw before and after the 6 weeks.
Eligibility Criteria
Inclusion Criteria:
* Cholesterol reading of 190 to 225 mg/dL
* Age 21-59 years old
Exclusion Criteria:
* Uncontrolled diabetes
* Hypothyroidism or other hormonal problems that have not stabilized
* Any liver diseases being actively treated
* Cancer
* Renal dialysis use
* Rheumatoid arthritis and related issues like lupus
* Inflammatory bowel disease
* Smoking
* Following a very restrictive diet
* Low blood pressure
* Statin drug use
* Having more than 5 alcoholic drinks per week
* Extreme obesity (BMI over 37)
* Pregnancy or lactation
* Allergies to milk protein
* History of discomfort after consuming whey protein
Source: ClinicalTrials.gov (NCT07101263). StuddyBuddy aggregates publicly available trial information.